Clinical Trial Update: Interleukin-1 Receptor Antagonist and Insulin Sensitivity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates the effect of an interleukin-1 receptor antagonist on insulin sensitivity in adults with type 2 diabetes and insulin resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Interleukin-1 Receptor Antagonist (Interleukin-1 receptor antagonist)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetes Mellitus, Type 2, Insulin Resistance | Phase 2 | Status: UNKNOWN